WNT signaling and AHCTF1 promote oncogenic MYC expression through super-enhancer-mediated gene gating

WNT signaling activates MYC expression in cancer cells. Here we report that this involves an oncogenic super-enhancer-mediated tethering of active MYC alleles to nuclear pores to increase transcript export rates. As the decay of MYC transcripts is more rapid in the nucleus than in the cytoplasm, the...

Full description

Saved in:
Bibliographic Details
Published inNature genetics Vol. 51; no. 12; pp. 1723 - 1731
Main Authors Scholz, Barbara A., Sumida, Noriyuki, de Lima, Carolina Diettrich Mallet, Chachoua, Ilyas, Martino, Mirco, Tzelepis, Ilias, Nikoshkov, Andrej, Zhao, Honglei, Mehmood, Rashid, Sifakis, Emmanouil G., Bhartiya, Deeksha, Göndör, Anita, Ohlsson, Rolf
Format Journal Article
LanguageEnglish
Published New York Nature Publishing Group US 01.12.2019
Nature Publishing Group
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:WNT signaling activates MYC expression in cancer cells. Here we report that this involves an oncogenic super-enhancer-mediated tethering of active MYC alleles to nuclear pores to increase transcript export rates. As the decay of MYC transcripts is more rapid in the nucleus than in the cytoplasm, the oncogenic super-enhancer-facilitated export of nuclear MYC transcripts expedites their escape from the nuclear degradation system in colon cancer cells. The net sum of this process, as supported by computer modeling, is greater cytoplasmic MYC messenger RNA levels in colon cancer cells than in wild type cells. The cancer-cell-specific gating of MYC is regulated by AHCTF1 (also known as ELYS), which connects nucleoporins to the oncogenic super-enhancer via β-catenin. We conclude that WNT signaling collaborates with chromatin architecture to post-transcriptionally dysregulate the expression of a canonical cancer driver. Oncogenic MYC expression involves super-enhancer-mediated tethering of MYC alleles to nuclear pores, thus increasing messenger RNA export. This is regulated by AHCTF1 and β-catenin.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1061-4036
1546-1718
1546-1718
DOI:10.1038/s41588-019-0535-3